Mutations in K-RAS gene occur frequently in NSCLC [20], more frequently (20–30%) in adenocarcinoma and less frequently (about 7%) in squamous-cell carcinoma [21]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.